On Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q4 2023 earnings per share (EPS) of -$3.75, up 113.37% year over year. Total Palisade Bio earnings for the quarter were -$2.99 million. In the same quarter last year, Palisade Bio's earnings per share (EPS) was $28.05.
As of Q2 2024, Palisade Bio's earnings has grown year over year. Palisade Bio's earnings in the past year totalled -$12.32 million.
What is PALI's earnings date?
Palisade Bio's earnings date is Invalid Date. Add PALI to your watchlist to be reminded of PALI's next earnings announcement.
What was PALI's revenue last quarter?
On Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Palisade Bio's revenue was $0.00.
What was PALI's revenue growth in the past year?
As of Q2 2024, Palisade Bio's revenue has grown null year over year. Palisade Bio's revenue in the past year totalled $250.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.